论文部分内容阅读
各型病毒性肝炎出现黄疸,可按血清胆红素(SB)浓度分为轻度(<85.5μmol/L)、中度(85.8～171μmol/L)及重度(>171μmol/L)。重度黄疸治疗难度大,若长期黄疸不退,可发生广泛性肝内泥砂样结石、胆汁性肝硬化,乃至肝细胞液化性或凝固性坏死。因此加速黄疸消退是改善肝炎预后的一个重要环节。目前,用于治疗重度黄疸的中西药物很多,择其常用而有一定疗效者予以介绍。
The incidence of jaundice in various types of viral hepatitis was mild (<85.5μmol / L), moderate (85.8-171μmol / L) and severe (> 171μmol / L) according to the concentration of serum bilirubin (SB) Severe jaundice treatment is difficult, if not long-term jaundice, widespread liver sediment-like stones, biliary cirrhosis, and even liver cell liquefaction or coagulation necrosis. Therefore, to accelerate the regression of jaundice is to improve the prognosis of hepatitis is an important part. At present, many Chinese and Western medicines for the treatment of severe jaundice, choose their common and have some effect to be introduced.